Results of transarterial chemoembolisation (TACE) therapy for hepatocellular carcinoma (HCC) in a general hospital in Singapore

被引:0
|
作者
Kwek, Andrew
Teo, Eng Kiong
Tan, Jessica
Fock, Kwong Ming
Chua, Tju Siang
Poh, Choo Hean
Gan, Lian Hoe
Tan, Poh Seng
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A179 / A179
页数:1
相关论文
共 50 条
  • [31] Combined Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation Therapy (SBRT) for Management of Primary Hepatocellular Carcinoma (HCC)
    Blacksburg, S. R.
    Zhang, E.
    Liu, J.
    Facciuto, M.
    Roayaie, S.
    Schwartz, M.
    Lookstein, R.
    Kim, E.
    Rosenzweig, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S319 - S319
  • [32] RETROSPECTIVE ANALYSIS OF 191 PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH TRANSARTERIAL CHEMOEMBOLISATION (TACE): VALIDATION OF THE ESTABLISHED AND CONSTRUCTION OF AN IMPROVED HCC-STAGING-SYSTEM
    den Winkel, M. Op
    Nagel, D.
    den Winkel, P. Op
    Sappl, J.
    Straub, G.
    Lamerz, R.
    Zech, C.
    Stieber, P.
    Kolligs, F. T.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S396 - S396
  • [33] Transarterial Chemoembolisation Is Highly Efficacious in Patients with Hepatocellular Carcinoma Unsuitable for Surgical Therapy
    Graziadei, Ivo
    Abbrederis, Nikolaus
    Chemelli, Andreas
    Jaschke, Werner
    Vogel, Wolfgang
    GASTROENTEROLOGY, 2009, 136 (05) : A861 - A862
  • [34] Thalidomide (Thal) tolerance in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Goldenberg, A
    Volm, M
    Hochster, H
    Muggia, F
    Rosen, R
    Teperman, L
    Morgan, G
    Schwartz, J
    Sung, M
    Wadler, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 376S - 376S
  • [35] Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Sapir, Eli
    Tao, Yebin
    Parikh, Neehar D.
    Bazzi, Latifa
    Devlin, Pauline
    Novelli, Paula M.
    Cuneo, Kyle Clifford
    Lawrence, Theodore Steven
    Schipper, Matthew J.
    Feng, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Transarterial Chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis -: Experiences
    Herber, S.
    Pitton, M.
    Moench, C.
    Schneider, J.
    Manzl, N.
    Kummer, I.
    Kanzler, S.
    Schuchmann, M.
    Junginger, T.
    Dueber, C.
    Otto, G.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (04): : 306 - 315
  • [37] Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Lawson, Alexander
    Kamarajah, Sivesh K.
    Parente, Alessandro
    Pufal, Kamil
    Sundareyan, Ramanivas
    Pawlik, Timothy M.
    Ma, Yuk Ting
    Shah, Tahir
    Kharkhanis, Salil
    Dasari, Bobby V. M.
    CANCERS, 2023, 15 (12)
  • [38] Transarterial chemoembolization (TACE) with doxorubicin eluting beads (DEB) for the treatment of hepatocellular carcinoma (HCC)
    Vit, A.
    De Pauli, F.
    Sponza, M.
    Mazzer, M.
    Foltran, L.
    Montanari, M.
    Piccoli, G.
    Fasola, G.
    Gasparini, D.
    Aprile, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Doxorubicin eluting bead (DEB) transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC)
    De Pauli, Federica
    Vit, Alessandro
    Aprile, Giuseppe
    Sponza, Massimo
    Iaiza, Emiliana
    Zanon, Elisa
    Piccoli, Gianluca
    Marzio, Andrea
    Giovannoni, Mariella
    Fasola, Gianpiero
    Gasparini, Daniele
    ANNALS OF ONCOLOGY, 2007, 18 : 9 - 9
  • [40] TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background
    Meyer, Tim
    Fox, Richard
    Ma, Yuk Ting
    Ross, Paul J.
    James, Martin
    Strugess, Richard
    Stubbs, Clive
    Wall, Lucy
    Watkinson, Anthony
    Hacking, Nigel
    Evans, T. R. Jeffry
    Collins, Peter
    Hubner, Richard
    Cunningham, David
    Primrose, John Neil
    Johnson, Philip James
    Palmer, Daniel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)